These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30926762)

  • 1. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression.
    Li H; Han S; Sun Q; Yao Y; Li S; Yuan C; Zhang B; Jing B; Wu J; Song Y; Wang H
    Aging (Albany NY); 2019 Mar; 11(6):1695-1715. PubMed ID: 30926762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
    Ou M; Li X; Zhao S; Cui S; Tu J
    EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ZFAS1 confers inflammatory responses and reduces cholesterol efflux in atherosclerosis through regulating miR-654-3p-ADAM10/RAB22A axis.
    Tang X; Yin R; Shi H; Wang X; Shen D; Wang X; Pan C
    Int J Cardiol; 2020 Sep; 315():72-80. PubMed ID: 32349937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
    Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
    Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 6. Silencing lncRNA CDKN2B-AS1 Alleviates Childhood Asthma Progression Through Inhibiting ZFP36 Promoter Methylation and Promoting NR4A1 Expression.
    Chen Z; Fan N; Shen G; Yang J
    Inflammation; 2023 Apr; 46(2):700-717. PubMed ID: 36422840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases.
    Song C; Qi Y; Zhang J; Guo C; Yuan C
    Curr Pharm Des; 2020; 26(41):5335-5346. PubMed ID: 32767927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.
    Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L
    FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCK1-AS1 promotes the proliferation, migration, invasion, and EMT of non-small cell lung cancer by regulating the miR-361-5p/ADAM10 axis.
    Wu B; Wang Z; Xu H; Chu X; Jiang Q
    Histol Histopathol; 2023 Dec; 38(12):1453-1464. PubMed ID: 36912070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA HOXC-AS1 Suppresses Ox-LDL-Induced Cholesterol Accumulation Through Promoting HOXC6 Expression in THP-1 Macrophages.
    Huang C; Hu YW; Zhao JJ; Ma X; Zhang Y; Guo FX; Kang CM; Lu JB; Xiu JC; Sha YH; Gao JJ; Wang YC; Li P; Xu BM; Zheng L; Wang Q
    DNA Cell Biol; 2016 Nov; 35(11):722-729. PubMed ID: 27574949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CDKN2B-AS1 hinders the proliferation and facilitates apoptosis of ox-LDL-induced vascular smooth muscle cells via the ceRNA network of CDKN2B-AS1/miR-126-5p/PTPN7.
    Li J; Chen J; Zhang F; Li J; An S; Cheng M; Li J
    Int J Cardiol; 2021 Oct; 340():79-87. PubMed ID: 34384839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer.
    Guo H; Yang S; Li S; Yan M; Li L; Zhang H
    Biomed Pharmacother; 2018 Jun; 102():749-757. PubMed ID: 29604594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2B-AS1 mediates proliferation and migration of vascular smooth muscle cells induced by insulin.
    Jin HJ; Wu ZH; Zhang BF; Deng J; Xu YD; Wang XY; Song ZY; Lu XW; Wang WT; Zheng XT
    Cell Tissue Res; 2023 Dec; 394(3):455-469. PubMed ID: 37907763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
    Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
    J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation.
    Zhu X; Li X; Zhu M; Xu K; Yang L; Han B; Huang R; Zhang A; Yao H
    J Neuroinflammation; 2018 Aug; 15(1):221. PubMed ID: 30075790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis.
    Müller M; Wetzel S; Köhn-Gaone J; Chalupsky K; Lüllmann-Rauch R; Barikbin R; Bergmann J; Wöhner B; Zbodakova O; Leuschner I; Martin G; Tiegs G; Rose-John S; Sedlacek R; Tirnitz-Parker JE; Saftig P; Schmidt-Arras D
    Oncotarget; 2016 Apr; 7(14):17431-41. PubMed ID: 26942887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CDKN2B-AS1 in atherosclerosis: Friend or foe?
    Mao Y; Yue H; Dong F
    Int J Cardiol; 2021 Nov; 343():106. PubMed ID: 34506826
    [No Abstract]   [Full Text] [Related]  

  • 18. Histone deacetylase inhibitor apicidin increases expression of the α-secretase ADAM10 through transcription factor USF1-mediated mechanisms.
    Hu XT; Zhu BL; Zhao LG; Wang JW; Liu L; Lai YJ; He L; Deng XJ; Chen GJ
    FASEB J; 2017 Apr; 31(4):1482-1493. PubMed ID: 28003340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
    Chi JS; Li JZ; Jia JJ; Zhang T; Liu XM; Yi L
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):816-822. PubMed ID: 29270737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM10 partially protects mice against influenza pneumonia by suppressing specific myeloid cell population.
    Okamori S; Ishii M; Asakura T; Suzuki S; Namkoong H; Kagawa S; Hegab AE; Yagi K; Kamata H; Kusumoto T; Ogawa T; Takahashi H; Yoda M; Horiuchi K; Hasegawa N; Fukunaga K
    Am J Physiol Lung Cell Mol Physiol; 2021 Nov; 321(5):L872-L884. PubMed ID: 34523355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.